Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...
The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives. Apple and Masimo have been ...
The medical-device maker is expected to operate as a stand-alone company within Danaher’s Diagnostics segment.
Zacks Investment Research on MSN
Masimo's board backs Danaher's $9.9B cash acquisition proposal
Masimo MASI recently entered into a definitive agreement, pursuant to which it will be acquired by the global conglomerate, Danaher DHR, for a total consideration of $9.9 billion. Per the deal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results